New England Commercial Real Estate, Q1 2026: A Cycle Map
April 18, 2026 | Author: David J. Murphy
A market moving in four directions at once
Ask a commercial real estate broker in Boston where we are in the cycle, and you’ll get five different answers – all correct, all about the same region, all dated the same quarter. That’s the defining feature of New England commercial real estate in Q1 2026. Each major sector sits at a different point on the traditional four-phase property cycle, and the gap between them has never been wider.
For investors, developers, and occupiers, the practical implication is this: “Where is the market?” is the wrong question in 2026. The right question is, “Which market?”
The framework, briefly
The standard real estate cycle, developed and popularized by University of Denver economist Glenn Mueller, runs through four phases: recovery (vacancy falling from a peak, no new construction, rents stabilizing), expansion (vacancy below equilibrium, rent growth accelerating, construction ramping), hyper-supply (new deliveries outpacing demand, vacancy rising, pipeline still full), and recession (vacancy well above equilibrium, rents declining, construction stalled, distressed transactions). Most markets move through these phases roughly in sync. New England in Q1 2026 is doing something different.
Life sciences: deep recession, possibly bottoming
The Cambridge-Boston lab market is the most dramatic commercial real estate story outside San Francisco office. According to Savills’ Q1 2026 Boston-Cambridge Life Sciences Market Report, overall vacancy stands at 26.8%, up 270 basis points year-over-year, with direct vacancy climbing 430 bps to 22.4%. Avison Young’s data shows the Greater Boston market recorded negative net absorption of 2.86 million square feet in 2025 – the first annual decline since 2011 – driven by large sublease availabilities, tenant consolidations, and bankruptcies.
Two transactions this quarter show where the cycle sits. Savills reports that A123 Systems acquired a 115,000-square-foot lab conversion at 10 Corporate Drive in Burlington from The Gutierrez Company for nearly $20 million, a roughly 52% discount to the $42 million the seller paid in 2021. In the same report, Savills noted that Alexandria Real Estate Equities will now market 401 Park Drive in Boston as office space rather than proceed with its planned lab conversion – a meaningful change from the sector’s largest specialist REIT, which itself posted a $1.1 billion loss in Q4 2025 according to Bisnow. Separately, Fierce Biotech confirmed in February that Takeda has listed more than 630,000 square feet of Cambridge space for sublease across multiple buildings as part of its consolidation into a new 600,000-square-foot campus at 585 Kendall Street.
But the floor may be closer than the headlines suggest. CBRE’s Q4 2025 U.S. Life Sciences Figures report, released in late January 2026, found that national lab vacancy declined 0.4 percentage points in Q4 2025 to 23.4% – the first quarterly drop since 2022. Savills’ own Q1 2026 data shows Boston-Cambridge sublease vacancy fell 160 bps year-over-year to 4.4%, meaning tenants are absorbing secondhand space faster than new inventory is coming online. The construction pipeline, which CBRE tracked at roughly 13 million square feet nationally in 2022, had fallen to 3.2 million by year-end 2025 with no new projects breaking ground, per Avison Young. And Avison Young’s U.S. Life Science Lead Tucker White called 2025 the strongest year for biotech venture capital since 2022.
Cycle position: Late recession, with the best-located Cambridge submarkets likely within 12 months of a bottom. Suburban lab is further behind.
Office: late recession transitioning into early recovery
Greater Boston office still looks ugly on the headlines. JLL’s Q1 2026 Boston office outlook measures overall vacancy at 24%; Cushman & Wakefield’s Q4 2025 MarketBeat puts it at 18.2%; Savills tracks availability at 22.2%, down from 24.4% a year earlier. Class A direct asking rent, per JLL, is holding steady at $51.42 per square foot.
The structural picture is shifting. According to JLL, direct availability fell below overall vacancy for the first time on record this quarter – meaning space is being absorbed or repurposed faster than new space is opening up. Cushman & Wakefield research manager Riley McMullan, interviewed by Boston.com in January, confirmed that 2025 leasing activity rose more than 72% over 2024 and that Q4 2025 posted the first quarter of positive net absorption since 2023. JLL’s Q1 2026 report highlights Keurig Dr Pepper’s 274,000-square-foot renewal in Burlington and AI firm Tutor Intelligence’s 36,000-square-foot lease in Watertown as the quarter’s headline deals. On the investment side, Bisnow’s Boston Deal Sheet reported that the FBI office tower in Chelsea traded for $134 million in April, and Connect CRE covered The Davis Companies’ acquisition of four Fort Point office buildings in January.
Cycle position: Transitioning out of recession into early recovery. Fragile. Whether Class A asking rents can break their current plateau will determine if recovery has real legs.
Industrial: late expansion rolling into rebalance
Industrial is the sector that spent the last five years in hyper-expansion and is now landing gracefully. Cushman & Wakefield data shows Boston-area industrial vacancy stabilized at 10.8% at the end of 2025 – 100 basis points higher than where the year began, but no longer accelerating. Avison Young’s Q1 2026 Boston Industrial Market Report characterizes this as a “healthy rebalance.”
The bifurcation inside the sector matters. Large-block vacancy remains elevated as tenants adjust to smaller footprints and operators digest the 2021–2023 speculative pipeline. Shallow-bay space along the 495/128 corridor, however, remains tight and landlord-friendly. In a New England Real Estate Journal 2026 outlook, a Colliers New Hampshire broker noted that fewer large users are actively searching for space in southern New Hampshire, with dozens of approved projects sitting unbuilt. Rhode Island industrial remains supply-constrained and landlord-friendly, per a Paramount Realty analysis published in NEREJ. Boston Real Estate Times reported in April that CBRE and VMD Companies secured 180,000 square feet in new leases at a Middleborough campus, with another 240,000 square feet of speculative space planned for summer 2026.
Cycle position: Late expansion transitioning to rebalance. The sector most likely to deliver steady, unspectacular returns in 2026.
Retail and multifamily: still in expansion
These two are the unexpected survivors.
Retail vacancy in New England sits near historic lows, the product of a decade of minimal new construction with resilient consumer demand. CBRE’s 2026 U.S. Real Estate Market Outlook for Boston forecasts continued historically low downtown retail vacancies, driven by experiential concepts. Grocery-anchored centers are outperforming, and experiential and “medtail” tenants are backfilling second-generation boxes – a pattern echoed across national reports from Cushman & Wakefield, WCRE, and MetLife Investment Management.
Multifamily remains a supply-constrained seller’s market in New England, distinct from the Sun Belt oversupply story. According to CBRE’s Boston multifamily group, Q1 2026 saw the sale of Twenty20, a 355-unit high-rise in East Cambridge’s Cambridge Crossing development, and a 151-unit Providence apartment portfolio (Chestnut Commons and 95 Lofts). Connect CRE reported that Kayne Anderson Real Estate and Mill Creek Residential broke ground on new multifamily development in January. The political wildcard: Bisnow reported in February that Boston Mayor Michelle Wu is backing a state-level rent control measure, reviving a debate Massachusetts voters rejected via Ballot Question 9 in 1994.
Cycle position: Mid-to-late expansion for both. Political risk is the variable to watch in multifamily.
Capital markets: the plumbing is still tight
Underneath the sector picture sits the capital stack, and here the news is mixed. Transactions are thawing – the FBI tower, Fort Point office portfolio, the $700 million Bally’s Rhode Island casino sale (Bisnow, February 2026), and the multifamily trades cited above – but pricing discovery is ongoing. Many deals are closing at meaningful discounts to 2021–2022 peaks. Federal Reserve Vice Chair for Supervision Michael Barr signaled in early 2026, in a Bloomberg interview subsequently covered by ABG Commercial Realty, that rates may not fall as quickly as CRE investors had hoped. The March rate spike tied to the Iran conflict pushed the 30-year fixed mortgage to a seven-month high of 6.57% per Mortgage Bankers Association data, tightening cap rates just as the spring buying season began. Cushman & Wakefield’s 2026 Cost Guide shows office fit-out costs across the Americas rose 5.5% in the past year, further pressuring underwriting.
What to watch for the rest of 2026
Three signals matter most from here. First, whether life sciences direct leasing activity – not just sublease absorption – accelerates into the second half of the year. Second, whether Class A office asking rents in Boston actually push higher rather than simply hold. And third, whether industrial large-block vacancy starts meaningfully leasing, or whether the bifurcation inside the sector hardens into a permanent two-tier market.
David J. Murphy is the managing attorney at Murphy PC in Boston, Massachusetts. He regularly represents real estate developers and investors in real estate development projects.